229 related articles for article (PubMed ID: 10675353)
1. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.
Wijnholds J; deLange EC; Scheffer GL; van den Berg DJ; Mol CA; van der Valk M; Schinkel AH; Scheper RJ; Breimer DD; Borst P
J Clin Invest; 2000 Feb; 105(3):279-85. PubMed ID: 10675353
[TBL] [Abstract][Full Text] [Related]
2. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.
Rao VV; Dahlheimer JL; Bardgett ME; Snyder AZ; Finch RA; Sartorelli AC; Piwnica-Worms D
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3900-5. PubMed ID: 10097135
[TBL] [Abstract][Full Text] [Related]
3. Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein.
Nishino J; Suzuki H; Sugiyama D; Kitazawa T; Ito K; Hanano M; Sugiyama Y
J Pharmacol Exp Ther; 1999 Jul; 290(1):289-94. PubMed ID: 10381789
[TBL] [Abstract][Full Text] [Related]
4. A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat.
Hosoya K; Hori S; Ohtsuki S; Terasaki T
Adv Drug Deliv Rev; 2004 Oct; 56(12):1875-85. PubMed ID: 15381338
[TBL] [Abstract][Full Text] [Related]
5. Usefulness and limitation of primary cultured porcine choroid plexus epithelial cells as an in vitro model to study drug transport at the blood-CSF barrier.
Angelow S; Zeni P; Galla HJ
Adv Drug Deliv Rev; 2004 Oct; 56(12):1859-73. PubMed ID: 15381337
[TBL] [Abstract][Full Text] [Related]
6. The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice.
Johnson DR; Finch RA; Lin ZP; Zeiss CJ; Sartorelli AC
Cancer Res; 2001 Feb; 61(4):1469-76. PubMed ID: 11245453
[TBL] [Abstract][Full Text] [Related]
7. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.
de Lange EC
Adv Drug Deliv Rev; 2004 Oct; 56(12):1793-809. PubMed ID: 15381334
[TBL] [Abstract][Full Text] [Related]
8. The antiepileptic drugs phenobarbital and carbamazepine reduce transport of methotrexate in rat choroid plexus by down-regulation of the reduced folate carrier.
Halwachs S; Lakoma C; Schäfer I; Seibel P; Honscha W
Mol Pharmacol; 2011 Oct; 80(4):621-9. PubMed ID: 21737571
[TBL] [Abstract][Full Text] [Related]
9. Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus.
Ghersi-Egea JF; Strazielle N
Microsc Res Tech; 2001 Jan; 52(1):83-8. PubMed ID: 11135451
[TBL] [Abstract][Full Text] [Related]
10. Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice.
Sasabe H; Kato Y; Suzuki T; Itose M; Miyamoto G; Sugiyama Y
J Pharmacol Exp Ther; 2004 Aug; 310(2):648-55. PubMed ID: 15131241
[TBL] [Abstract][Full Text] [Related]
11. Cellular transfer of macromolecules across the developing choroid plexus of Monodelphis domestica.
Liddelow SA; Dziegielewska KM; Ek CJ; Johansson PA; Potter AM; Saunders NR
Eur J Neurosci; 2009 Jan; 29(2):253-66. PubMed ID: 19200232
[TBL] [Abstract][Full Text] [Related]
12. Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant.
Tachikawa M; Fujinawa J; Takahashi M; Kasai Y; Fukaya M; Sakai K; Yamazaki M; Tomi M; Watanabe M; Sakimura K; Terasaki T; Hosoya K
J Neurochem; 2008 Nov; 107(3):768-78. PubMed ID: 18761709
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage.
Wijnholds J; Scheffer GL; van der Valk M; van der Valk P; Beijnen JH; Scheper RJ; Borst P
J Exp Med; 1998 Sep; 188(5):797-808. PubMed ID: 9730882
[TBL] [Abstract][Full Text] [Related]
14. PEPT2 (Slc15a2)-mediated unidirectional transport of cefadroxil from cerebrospinal fluid into choroid plexus.
Shen H; Keep RF; Hu Y; Smith DE
J Pharmacol Exp Ther; 2005 Dec; 315(3):1101-8. PubMed ID: 16107517
[TBL] [Abstract][Full Text] [Related]
15. Peptide and peptide analog transport systems at the blood-CSF barrier.
Smith DE; Johanson CE; Keep RF
Adv Drug Deliv Rev; 2004 Oct; 56(12):1765-91. PubMed ID: 15381333
[TBL] [Abstract][Full Text] [Related]
16. Thyroxine (T4) transfer from CSF to choroid plexus and ventricular brain regions in rabbit: contributory role of P-glycoprotein and organic anion transporting polypeptides.
Kassem NA; Deane R; Segal MB; Chen R; Preston JE
Brain Res; 2007 Nov; 1181():44-50. PubMed ID: 17915195
[TBL] [Abstract][Full Text] [Related]
17. Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.
Strazielle N; Khuth ST; Ghersi-Egea JF
Adv Drug Deliv Rev; 2004 Oct; 56(12):1717-40. PubMed ID: 15381331
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance caused by multidrug resistance-associated proteins.
Wijnholds J
Novartis Found Symp; 2002; 243():69-79; discussion 80-2, 180-5. PubMed ID: 11990783
[TBL] [Abstract][Full Text] [Related]
19. The distributional nexus of choroid plexus to cerebrospinal fluid, ependyma and brain: toxicologic/pathologic phenomena, periventricular destabilization, and lesion spread.
Johanson C; Stopa E; McMillan P; Roth D; Funk J; Krinke G
Toxicol Pathol; 2011 Jan; 39(1):186-212. PubMed ID: 21189316
[TBL] [Abstract][Full Text] [Related]
20. A clearance system for prostaglandin D2, a sleep-promoting factor, in cerebrospinal fluid: role of the blood-cerebrospinal barrier transporters.
Tachikawa M; Tsuji K; Yokoyama R; Higuchi T; Ozeki G; Yashiki A; Akanuma S; Hayashi K; Nishiura A; Hosoya K
J Pharmacol Exp Ther; 2012 Dec; 343(3):608-16. PubMed ID: 22931759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
